• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

6.850 -0.160 (-2.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,912,668
Open 7.070
Bid (Size) 6.830 (5)
Ask (Size) 6.860 (7)
Prev. Close 7.010
Today's Range 6.780 - 7.120
52wk Range 5.010 - 17.22
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novavax Announces Positive Preclinical Data From Bird Flu Vaccine: Retail Wonders When Will The Stock Be Fairly Valued
July 24, 2025
Via Stocktwits
Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates
July 24, 2025
Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose preclinical studies. 
Via Benzinga

Performance

YTD
-20.1%
-20.1%
1 Month
+8.7%
+8.7%
3 Month
+6.7%
+6.7%
6 Month
-28.0%
-28.0%
1 Year
-58.3%
-58.3%

More News

Read More
2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet
July 11, 2025
Via The Motley Fool
Topics Cannabis
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
July 10, 2025
Via Benzinga
Topics Intellectual Property
Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks
July 08, 2025
Via Benzinga
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma
July 08, 2025
Via Stocktwits
RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval
July 03, 2025
Via Benzinga
CDC Vaccine Panel Overhauled by RFK Jr. Votes To Drop Mercury Preservative, Critics Sound Alarm
June 26, 2025
Via Stocktwits
Moderna, Pfizer, Novavax Draw Bearish Buzz Ahead Of CDC Panel With Vaccine Skeptics
June 25, 2025
Via Stocktwits
Why Is Cidara Therapeutics Stock Trading Higher On Monday?
June 23, 2025
Via Benzinga
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
June 17, 2025
Via Benzinga
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal
June 12, 2025
Via Benzinga
RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Report
June 12, 2025
Via Benzinga
Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial
June 11, 2025
Via Benzinga
Novavax’s Covid-Flu Combo, Standalone Flu Vaccines Demonstrate Robust Immune Response In Late-Stage Trial: Retail Says It’s ‘A Very Good Sign’
June 11, 2025
Via Stocktwits
American Pharmacists Association Withholds Endorsement Of CDC's Revised COVID-19 Vaccine Guidance
June 10, 2025
Via Benzinga
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?
June 10, 2025
Via Stocktwits
Topics Government
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.
June 09, 2025
Via Investor's Business Daily
Topics Government
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts
June 06, 2025
Via Benzinga
Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals
June 02, 2025
Via Benzinga
RFK Jr. Drops COVID Vaccine Recommendation For Healthy Kids, But Experts Warn Of Major Risks
May 30, 2025
Via Benzinga
Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort
May 29, 2025
Via Benzinga
Topics Government
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children
May 27, 2025
Via Benzinga
Analysts Think These Stocks Could More Than Double in Value
May 23, 2025
Via MarketBeat
Topics World Trade
What's Driving the Market Sentiment Around Novavax?
May 21, 2025
Via Benzinga

Frequently Asked Questions

Is Novavax, Inc. - Common Stock publicly traded?
Yes, Novavax, Inc. - Common Stock is publicly traded.
What exchange does Novavax, Inc. - Common Stock trade on?
Novavax, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Novavax, Inc. - Common Stock?
The ticker symbol for Novavax, Inc. - Common Stock is NVAX on the Nasdaq Stock Market
What is the current price of Novavax, Inc. - Common Stock?
The current price of Novavax, Inc. - Common Stock is 6.850
When was Novavax, Inc. - Common Stock last traded?
The last trade of Novavax, Inc. - Common Stock was at 07/30/25 04:00 PM ET
What is the market capitalization of Novavax, Inc. - Common Stock?
The market capitalization of Novavax, Inc. - Common Stock is 510.22M
How many shares of Novavax, Inc. - Common Stock are outstanding?
Novavax, Inc. - Common Stock has 510M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap